Application of machine learning in the prognosis prediction of malignant large bowel obstruction: a two-cohort study

Author:

Chen Shuai1,Zhang Jun-Rong1,Li Zhen-Lu2,Huang Cang-Dian1,Tu Peng-Sheng1,Chen Wen-Xuan1,Shang-Guan Xin-Chang1,Wu Chang-Liang2,Chen Xian-Qiang1

Affiliation:

1. Fujian Medical University Union Hospital

2. The Affiliated Hospital of Qingdao University

Abstract

Abstract

Background The Colon and Rectal NCCN Clinical Practice Guidelines currently identify obstructions as risk factors rather than as specific types. A personalized and intelligent prognostic evaluation system for malignant large bowel obstruction (MLBO) is urgently needed. Methods We conducted a retrospective study on 170 MLBO patients who underwent radical excision at two centers. The training and validation sets were randomly derived from the combined data of each center at a 7:3 ratio. We employed machine learning methods, including the logistic regression classifier (LR), linear discriminant analysis classifier (LDA), extreme gradient boosting classifier (XGB), AdaBoost classifier (AB), and light gradient boosting machine classifier (LGBM). These classifiers were based on clinical features (clinical model), radiological features (radiomics model), and their combination (merged model). The best model was identified through the area under the operating characteristic curve (AUC). Results Using clinicopathologic parameters, clinicopathologic models XGB achieved an impressive AUC of 0.97 for DFS, and LDA maintained strong performance with an AUC of 0.92 for OS, rather than radio-omics and dual-omics models. Using the Qingdao Center(QD) dataset as a single validation set, the model performance was not ideal due to demographic differences, with AUC values of 0.42 and 0.50 for DFS and OS, respectively. Finally, when cross-training and validating clinicopathological features from two centers were conducted, LDA exhibited exceptional performance for both DFS and OS, with AUCs of 0.96 and 0.95, respectively. Regardless of DFS or OS, the worse prognosis group had higher levels of the following metrics compared to the better prognosis group. [For DFS: pT(p < 0.001), pN(p < 0.006), pM(p < 0.001), monocyte count(0.64 vs. 0.52, p = 0.038), and carbohydrate antigen 199(CA199) (27.59 vs. 15.14, p = 0. 006); For OS: pT(p = 0.002), pN(p = 0.002) and pM(p < 0.001), as well as LVI (p = 0.037), monocyte count(0.68 vs. 0.51, p = 0.005) and CA199 (31.78 vs. 15.88, p = 0.006)]. Conclusions High-efficacy models for the prognosis prediction of MLBO via clinicopathological features across two centers was constructed. We recommend heightened vigilance for MLBO patients with a high TNM stage, lymphovascular invasion occurrence, elevated CA199 levels, and high monocyte count.

Publisher

Research Square Platform LLC

Reference50 articles.

1. Siegel R, Miller K, Wagle N, Jemal A, Cancer statistics. 2023. CA: a cancer journal for clinicians. 2023;73(1):17–48.

2. *Al B, Benson I, Chair † Robert MD, Venook H, Mohamed Adam MV-CUHDFCCC, Mahmoud MUHDFCCC, Al-Hawary M, MфUoMRCC Y-J, Chen M, PhD § City of Hope National Medical Center., Kristen K. Ciombor MV-ICC, NCCN Clinical Practice Guidelines in Oncology Rectal Cancer Version 6.2023. Journal of the National Comprehensive Cancer Network : JNCCN. 2023.

3. *Al B, Benson I, Chair † Robert MD, Venook H, Mohamed Adam MV-CUHDFCCC, Mahmoud MUHDFCCC, Al-Hawary M, MфUoMRCC Y-J, Chen M, PhD § City of Hope National Medical Center., Kristen K. Ciombor MV-ICC, NCCN Clinical Practice Guidelines in Oncology Colon Cancer Version 4.2023. Journal of the National Comprehensive Cancer Network : JNCCN. 2023.

4. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation;Pisano M;World J Emerg surgery: WJES,2018

5. Cancer statistics, 2020;Rebecca LS;CA Cancer J Clin,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3